Search Results - "Wiesinger H"

Fast neutron irradiation and flux pinning in single crystalline high temperature superconductors.

Authors: Sauerzopf, F. M. Wiesinger, H. P. Kritscha, W.

Source: Cryogenics; 1993, Vol. 33 Issue 1, p8-13, 6p

Anisotropic current flow and demagnetization corrections in the Bean model.

Authors: Sauerzopf, F. M. Wiesinger, H. P. Weber, H. W.

Source: Cryogenics; July 1990, Vol. 30, p650-655, 6p

This result is not displayed to guests.
Login for full access.

Deep endometriosis, including intestinal involvement – the interdisciplinary approach.

Authors: Keckstein, J. Wiesinger, H.

Source: Minimally Invasive Therapy & Allied Technologies. Jun2005, Vol. 14 Issue 3, p160-166. 7p.

Whole-body vibration training induces hypertrophy of the human patellar tendon.

Authors: Rieder, F. Wiesinger, H.‐P. Kösters, A. et al.

Source: Scandinavian Journal of Medicine & Science in Sports (John Wiley & Sons, Inc.). Aug2016, Vol. 26 Issue 8, p902-910.

Alpine Skiing With total knee ArthroPlasty ( ASWAP): muscular adaptations.

Authors: Rieder, F. Kösters, A. Wiesinger, H.‐P. et al.

Source: Scandinavian Journal of Medicine & Science in Sports (John Wiley & Sons, Inc.). Aug2015 Supplement 2, Vol. 25, p26-32.

Alpine Skiing With total knee ArthroPlasty ( ASWAP): effect on tendon properties.

Authors: Kösters, A. Rieder, F. Wiesinger, H.‐P. et al.

Source: Scandinavian Journal of Medicine & Science in Sports (John Wiley & Sons, Inc.). Aug2015 Supplement 2, Vol. 25, p67-73.

Immediate effects of whole body vibration on patellar tendon properties and knee extension torque.

Authors: Rieder, F. Wiesinger, H.-P. Kösters, A. et al.

Source: European Journal of Applied Physiology. Mar2016, Vol. 116 Issue 3, p553-561. 9p.

INDUCTION OF ARGININOSUCCINATE SYNTHETASE IN RAT BRAIN GLIAL CELLS AFTER STRIATAL MICROINJECTION OF IMMUNOSTIMULANTS.

Authors: Wiesinger, H. Schmidlin, A. Heneka, M.

Source: Journal of Neurochemistry. Jul99 Supplement, Vol. 73, pS73-S73. 1/4p.

Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial.

Authors: Arnold, D. Voigt, W. Kiewe, P. et al.

Source: British Journal of Cancer. 10/20/2009, Vol. 101 Issue 8, p1241-1247. 7p. 4 Charts, 2 Graphs.

Good servant, bad master: sulfide influence on partial nitritation of sewage.

Authors: Kouba, V. Proksova, E. Vejmelkova, D. et al.

Source: Water Science & Technology. 2017, Vol. 76 Issue 12, p3258-3268. 11p. 1 Color Photograph, 1 Chart, 4 Graphs.

Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.

Authors: Stupp, R. Tosoni, A. Bromberg, J. E. C. et al.

Source: Annals of Oncology. Sep2011, Vol. 22 Issue 9, p2144-2149. 6p. 1 Diagram, 3 Charts, 2 Graphs.

Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors.

Authors: Schmid, P. Kiewe, P. Possinger, K. et al.

Source: Annals of Oncology. Mar2010, Vol. 21 Issue 3, p633-639. 7p. 5 Charts, 1 Graph.

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI()), in patients with advanced solid tumours.

Authors: Scott EN Thomas AL Molife LR et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2009, Vol. 64 Issue 2, p425-429. 5p.

Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)

Authors: Graham JS Plummer R McCoy C et al.

Source: European Journal of Cancer. Oct2008, Vol. 44 Issue 15, p2162-2168. 7p.

Patient perceptions that limit a community-based intervention to promote participation.

Authors: Towle A Godolphin W Manklow J et al.

Source: Patient Education & Counseling. Jul2003, Vol. 50 Issue 3, p231-233. 3p.

Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies.

Authors: Feldmüller M Jodl SJ Ploeger B et al.

Source: Frontiers in pharmacology [Front Pharmacol] 2025 May 30; Vol. 16, pp. 1521505. Date of Electronic Publication: 2025 May 30 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Publisher Correction: Inflammatory bowel disease uncovered in fecal immunochemical test positive patients in a Canadian provincial colon cancer screening program.

Authors: Bedi H Telford J Penner R et al.

Source: Scientific reports [Sci Rep] 2026 Apr 10; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 10.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; In Process

Novel aldo-keto reductase 1C3 inhibitor affects androgen metabolism but not ovarian function in healthy women: a phase 1 study.

Authors: Gashaw I Reif S Wiesinger H et al.

Source: European journal of endocrinology [Eur J Endocrinol] 2023 Jul 10; Vol. 188 (7), pp. 578-591.

Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE

Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolution.

Authors: Elsner F Hoffmann M Fahrioglu-Yamaci R et al.

Source: The Journal of pathology [J Pathol] 2022 Nov; Vol. 258 (3), pp. 250-263. Date of Electronic Publication: 2022 Sep 23.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley And Sons Country of Publication: England NLM ID: 0204634 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9896 (Electronic) Linking ISSN: 00223417 NLM ISO Abbreviation: J Pathol Subsets: MEDLINE